Symposia

Optimizing Treatment Approaches and Evolution of HER2 Targeting in mCRC

Session Chair(s)

• 

  Thierry André, MD

  Hopital Saint Antoine
  Paris, France

Supported by Seagen

Presentations:

• 13:30 – 13:40

  Welcome and Introduction
  

  Session Chair: Thierry André, MD – Hopital Saint Antoine
• 13:40 – 13:55

  Evolution of HER2 as an Actionable Target Across Solid Tumors
  

  Session Speaker: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center
• 13:55 – 14:10

  HER2 in mCRC - From Diagnosis to Early Clinical Trials
  

  Session Speaker: Andrea Sartore-Bianchi, MD – Grande Ospedale Metropolitano Niguarda, Università degli Studi di Milano
• 14:10 – 14:25

  Clinical Evolution of Targeted Treatments for HER2+ mCRC Patients
  

  Session Speaker: Jonathan Strickler, MD
• 14:25 – 14:55

  Panel Discussion and Interactive Q&A
  

  Session Moderator: Thierry André, MD – Hopital Saint Antoine

  Session Speaker: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center

  Session Speaker: Andrea Sartore-Bianchi, MD – Grande Ospedale Metropolitano Niguarda, Università degli Studi di Milano

  Session Panelist: Jonathan Strickler, MD
• 14:55 – 15:00

  Closing Remarks and Farewell
  

  Session Chair: Thierry André, MD – Hopital Saint Antoine